Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Timeline

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jun 25, 2023 8:37am

202 Views

Post# 35513456

RE:RE:RE:RE:Timeline

I got around to listening to the radio interview. RW does mention BTD AA Priority review at the end.

So, I guess there is nothing new. We should get 'Formal' FDA approval in the '25-'26 timeframe. Yet we could still receive AA by end of this year, if BTD is applied for soon. Which it seems they are working on.

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports